Deerfield Management

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. As of 2018, CureDuchenne's portfolio includes 16 wide-ranging projects with 4 successful exits. Investments from CureDuchenne Ventures have successfully leveraged more than $1.3 billion in follow-on financing from venture capital, biotech, and pharmaceutical companies to fund emerging projects to find treatments for Duchenne.